|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 23, 2017 ) Antiviral Drugs helps in combating viral infections by hampering the replication of viruses and strengthening the immune response to the viral infection. From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad spectrum antiviral drugs that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections. Latin America is among the emerging market for the product.
View Full Report @ http://www.marketdataforecast.com/market-reports/latin-america-antiviral-drugs-market-1591/
The growth of antiviral drugs in Latin American market is majorly driven by factors such as increased public awareness, emergence of life-threatening diseases, introduction of innovative drugs, and increase in viral infection incidences. As per recent research, approximately 6 million people are infected with hepatitis C in Latin America. Hepatitis C virus infection causes chronic liver disease, cirrhosis and hepatocellular carcinoma. The government in Latin America region, specifically Brazil has been working on to introduce new antiviral drugs for people infected with chronic hepatitis C as well people co-infected with HIV/AIDS and Hepatitis C. Thus, the market for antiviral drug is expected to grow significantly in Latin America. The key restraints of the market are high cost involved in drug development, restricted trade policies, and side-effects of products such as nausea, diarrhea, and behavioral changes.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/latin-america-antiviral-drugs-market-1591/request-sample
Latin America Antiviral Drugs Market is segmented on the basis of Application, Target, and End-Users. Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA polymerase, NS3 Protease, Reverse transcriptase, and Others. On the basis of End-Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers. The Latin America market is geographically segmented into Brazil, Argentina, Mexico and rest of Latin America.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/latin-america-antiviral-drugs-market-1591/inquire
The major companies dominating the Antiviral Drugs Market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
